-
Cy5 NHS ester(Et): Practical Guide for Protein Fluorescent L
2026-06-10
Cy5 NHS ester(Et) enables efficient, water-soluble fluorescent labeling of primary amines in proteins, peptides, and related biomolecules for immediate-use detection workflows. It is well-suited for immunofluorescence staining, flow cytometry, and fluorescence microscopy, but should not be applied in ethanol-based protocols or when extended storage of dye solutions is required.
-
CBD Modulates Endocannabinoid Pathways to Treat Orofacial Pa
2026-06-09
This study delineates how cannabidiol (CBD) alleviates both the sensory and affective facets of orofacial inflammatory pain through coordinated modulation of peripheral and central endocannabinoid signaling. The findings highlight CBD’s translational promise as a multifaceted therapeutic agent for pain and pain-related emotional disturbances.
-
FDA-Approved Drugs Inhibit MERS-CoV: Lopinavir's Antiviral R
2026-06-09
de Wilde et al. systematically screened FDA-approved compounds for anti-MERS-CoV activity, identifying four drugs—including Lopinavir—that inhibited coronavirus replication in cell culture at low micromolar concentrations. This work provides a translational bridge between known antiviral agents and emerging infectious disease research, highlighting Lopinavir’s potential for rapid repurposing in coronavirus outbreaks.
-
Bazedoxifene as a Third-Generation SERM in Osteoporosis Ther
2026-06-08
This review critically examines Bazedoxifene’s efficacy, safety, and mechanistic role as a third-generation selective estrogen receptor modulator (SERM) in postmenopausal osteoporosis. The reference study details its modest improvements in lumbar spine bone mineral density and significant vertebral fracture reduction, while clarifying its risk profile and position among antiresorptive agents.
-
Intravesical p21 mRNA–LNP Therapy: Advances in Bladder Cance
2026-06-08
This study introduces a non-viral, intravesical delivery system using p21 mRNA–loaded lipid nanoparticles to restore tumor suppressor function in bladder cancer. The approach achieves robust local protein expression and significant tumor inhibition, supporting the potential of localized mRNA therapies for urologic malignancies.
-
2'3'-cGAMP (Sodium Salt) in STING Pathway Research: Protocol
2026-06-07
2'3'-cGAMP (sodium salt) enables unmatched precision in dissecting the STING-mediated innate immune response and type I interferon induction, with robust water solubility and benchmark potency. Advanced workflows leveraging this molecule accelerate immunotherapy research and nanoparticle delivery innovations.
-
Dual Targeting of Caspase-8/c-FLIPL and MCL1 in Pancreatic C
2026-06-06
This study demonstrates that pharmacological activation of the caspase-8/c-FLIPL heterodimer, in combination with MCL1 inhibition, synergistically enhances apoptotic cell death in pancreatic cancer cells. The findings provide a mechanistic rationale for co-targeting extrinsic and intrinsic apoptosis pathways to overcome cancer cell resistance.
-
VX-702 and the Evolution of Dual-Action p38α MAPK Inhibition
2026-06-05
This thought-leadership article explores how VX-702, a next-generation p38α MAPK inhibitor, is transforming inflammation and translational disease research. By integrating recent mechanistic insights into kinase and phosphatase dynamics, we provide a strategic roadmap for researchers leveraging VX-702 in advanced experimental models. The article highlights VX-702’s dual-action inhibition—simultaneously blocking kinase activity and accelerating dephosphorylation—and contextualizes these features within the competitive landscape, translational relevance, and future directions. Practical guidance, protocol parameters, and links to foundational studies and product resources empower investigators to optimize their research workflows.
-
Digoxin in Translational Models: Cardiac and Antiviral Insig
2026-06-05
Explore the multifaceted role of Digoxin as a Na+/K+ ATPase pump inhibitor in both cardiac and antiviral research. This article offers advanced scientific analysis, bridging mechanistic insights and practical protocols for innovative research applications.
-
EV-Transferred ACLY Drives Immunosuppressive TAM Differentia
2026-06-04
This study identifies a novel mechanism by which hepatocellular carcinoma (HCC) cells transfer ATP-citrate lyase (ACLY) to monocytes via extracellular vesicles (EVs), promoting their differentiation into tumor-associated macrophages (TAMs) with immunosuppressive properties. The findings establish EV-mediated delivery of ACLY as a targetable axis to enhance immunotherapy in liver cancer.
-
Berbamine Hydrochloride: Precision NF-κB Activity Inhibitor
2026-06-04
Berbamine hydrochloride enables high-fidelity NF-κB signaling pathway inhibition and ferroptosis modulation in advanced cancer models, offering unique workflow flexibility. This guide translates cutting-edge findings into optimized protocols and troubleshooting tips for experimental success.
-
Biotin (Vitamin B7) in Advanced Protein Biotinylation Workfl
2026-06-03
Biotin (Vitamin B7) transforms molecular biology workflows by enabling highly specific protein labeling and metabolic assays. Explore step-by-step protocols, expert troubleshooting, and strategic insights that leverage APExBIO’s high-purity Biotin for sensitive, reproducible results.
-
STING agonist-1: Advancing B Cell Activation and TLS Researc
2026-06-03
STING agonist-1 from APExBIO enables precise activation of the STING pathway, empowering researchers to dissect intricate mechanisms of innate immunity, B cell-driven antitumor responses, and tertiary lymphoid structure formation. This guide delivers actionable workflows, troubleshooting strategies, and direct translational insights for immunology and cancer research.
-
Cholesterol’s Role in Membrane Engineering for mRNA Delivery
2026-06-02
This article explores the mechanistic and translational significance of cholesterol as the principal sterol in the design and optimization of lipid nanoparticle (LNP) systems for mRNA delivery in cancer therapy. Drawing on recent open-access work in bladder cancer, we illuminate how cholesterol’s biophysical properties directly influence membrane fluidity, endosomal escape, and payload release—critical parameters for researchers advancing localized mRNA therapeutics. Strategic advice for translational scientists is offered, including protocol considerations and future outlook, while highlighting the unique value proposition of APExBIO’s high-purity cholesterol for next-generation LNP and membrane studies.
-
DiscoveryProbe Protease Inhibitor Library: Applied Workflows
2026-06-02
The DiscoveryProbe™ Protease Inhibitor Library enables high-throughput, reproducible protease inhibition studies across apoptosis, cancer, and infectious disease models. This article details stepwise workflows, troubleshooting strategies, and practical enhancements for robust assay performance, drawing on peer-reviewed advances and APExBIO's benchmark standards.